Fortis Healthcare [FORTIS] vs Aster DM Healthcare [ASTERDM] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Fortis Healthcare Ltd. wins in 13 metrics, Aster DM Healthcare Ltd. wins in 7 metrics, with 0 ties. Fortis Healthcare Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Fortis Healthcare Ltd. | Aster DM Healthcare Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 72.46 | 110.37 | Fortis Healthcare Ltd. |
| Price-to-Book Ratio | 7.40 | 8.03 | Fortis Healthcare Ltd. |
| Debt-to-Equity Ratio | 32.96 | 43.79 | Fortis Healthcare Ltd. |
| PEG Ratio | -3.35 | -2.33 | Aster DM Healthcare Ltd. |
| EV/EBITDA | 38.35 | 46.61 | Fortis Healthcare Ltd. |
| Profit Margin (TTM) | 10.94% | 7.33% | Fortis Healthcare Ltd. |
| Operating Margin (TTM) | 17.02% | 12.11% | Fortis Healthcare Ltd. |
| EBITDA Margin (TTM) | 17.02% | 12.11% | Fortis Healthcare Ltd. |
| Return on Equity | 8.44% | 147.28% | Aster DM Healthcare Ltd. |
| Return on Assets (TTM) | 5.65% | 81.40% | Aster DM Healthcare Ltd. |
| Free Cash Flow (TTM) | $5.77B | $683.20M | Fortis Healthcare Ltd. |
| Dividend Yield | 0.12% | 1.05% | Aster DM Healthcare Ltd. |
| 1-Year Return | 31.35% | 43.05% | Aster DM Healthcare Ltd. |
| Price-to-Sales Ratio (TTM) | 7.94 | 8.17 | Fortis Healthcare Ltd. |
| Enterprise Value | $722.34B | $373.17B | Fortis Healthcare Ltd. |
| EV/Revenue Ratio | 8.23 | 8.37 | Fortis Healthcare Ltd. |
| Gross Profit Margin (TTM) | 55.42% | 77.44% | Aster DM Healthcare Ltd. |
| Revenue per Share (TTM) | $116 | $87 | Fortis Healthcare Ltd. |
| Earnings per Share (Diluted) | $12.74 | $6.39 | Fortis Healthcare Ltd. |
| Beta (Stock Volatility) | 0.67 | -0.06 | Aster DM Healthcare Ltd. |
Fortis Healthcare Ltd. vs Aster DM Healthcare Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Fortis Healthcare Ltd. | -1.03% | -0.90% | 1.71% | 21.32% | 12.69% | 8.84% |
| Aster DM Healthcare Ltd. | -3.47% | 2.68% | 4.39% | 21.18% | 27.32% | 29.67% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Fortis Healthcare Ltd. | 31.35% | 219.26% | 326.88% | 512.08% | 521.49% | 885.42% |
| Aster DM Healthcare Ltd. | 43.05% | 181.55% | 407.76% | 372.16% | 372.16% | 372.16% |
Performance & Financial Health Analysis: Fortis Healthcare Ltd. vs Aster DM Healthcare Ltd.
| Metric | FORTIS | ASTERDM |
|---|---|---|
| Market Information | ||
| Market Cap | ₹699.66B | ₹364.57B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 1,586,827 | 556,447 |
| 90 Day Avg. Volume | 1,692,133 | 656,240 |
| Last Close | ₹980.15 | ₹786.70 |
| 52 Week Range | ₹743.65 - ₹1,104.30 | ₹519.10 - ₹836.50 |
| % from 52W High | -11.24% | -5.95% |
| All-Time High | ₹1,104.30 (Oct 17, 2025) | ₹836.50 (Jun 12, 2026) |
| % from All-Time High | -11.24% | -5.95% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.18% | 0.13% |
| Quarterly Earnings Growth | -0.22% | -0.08% |
| Financial Health | ||
| Profit Margin (TTM) | 0.11% | 0.07% |
| Operating Margin (TTM) | 0.17% | 0.12% |
| Return on Equity (TTM) | 0.08% | 1.47% |
| Debt to Equity (MRQ) | 32.96 | 43.79 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹124.78 | ₹87.77 |
| Cash per Share (MRQ) | ₹5.62 | ₹24.81 |
| Operating Cash Flow (TTM) | ₹10.16B | ₹54.10B |
| Levered Free Cash Flow (TTM) | ₹7.74B | ₹53.78B |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.12% | 1.05% |
| Last 12-Month Dividend | ₹1.00 | ₹6.00 |
Valuation & Enterprise Metrics Analysis: Fortis Healthcare Ltd. vs Aster DM Healthcare Ltd.
| Metric | FORTIS (Apr 24, 2026) | ASTERDM (Apr 26, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 72.46 | 110.37 |
| Forward P/E | 48.33 | 60.80 |
| PEG Ratio | -3.35 | -2.33 |
| Price to Sales (TTM) | 7.94 | 8.17 |
| Price to Book (MRQ) | 7.40 | 8.03 |
| Market Capitalization | ||
| Market Capitalization | ₹699.66B | ₹364.57B |
| Enterprise Value | ₹722.34B | ₹373.17B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 8.23 | 8.37 |
| Enterprise to EBITDA | 38.35 | 46.61 |
| Risk & Other Metrics | ||
| Beta | 0.67 | -0.06 |
| Book Value per Share (MRQ) | ₹124.78 | ₹87.77 |
Financial Statements Comparison: Fortis Healthcare Ltd. vs Aster DM Healthcare Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | FORTIS (2025) | ASTERDM (2025) |
|---|---|---|
| Revenue/Sales | 77.24B | 40.69B |
| Cost of Goods Sold | 35.39B | 9.38B |
| COGS % of Revenue | 45.8% | 23.1% |
| Gross Profit | 41.85B | 31.31B |
| Gross Margin | 54.2% | 76.9% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | 11.93B | 5.25B |
| Operating Margin | 15.4% | 12.9% |
| EBITDA | 16.43B | 8.75B |
| EBITDA Margin | 21.3% | 21.5% |
| Pre-Tax Income | 10.07B | 4.71B |
| Pre-Tax Income % of Revenue | 13.0% | 11.6% |
| Income Tax | 1.98B | 1.34B |
| Income Tax % of Revenue | 2.6% | 3.3% |
| Net Income (Profit) | 8.09B | 54.08B |
| Profit Margin | 10.5% | 132.9% |
Balance Sheet & Liquidity Metrics
| Metric | FORTIS (2025) | ASTERDM (2025) |
|---|---|---|
| Cash & Equivalents | 1.40B | 1.65B |
| Total Current Assets | 14.71B | 19.01B |
| Total Current Assets % of Revenue | 19.0% | 46.7% |
| Total Current Liabilities | 16.07B | 8.79B |
| Total Current Liabilities % of Revenue | 20.8% | 21.6% |
| Long-Term Debt | 23.11B | 18.29B |
| Long-Term Debt % of Revenue | 29.9% | 45.0% |
| Total Shareholders Equity | 91.69B | 36.51B |
| Retained Earnings | 6.54B | -1.52B |
| Retained Earnings % of Revenue | 8.5% | -3.7% |
| Property, Plant & Equipment | 22.30B | 12.75B |
Cash Flow Statement Comparison
| Metric | FORTIS (2025) | ASTERDM (2025) |
|---|---|---|
| Operating Cash Flow | 10.16B | 54.10B |
| Operating Cash Flow % of Revenue | 13.2% | 132.9% |
| Capital Expenditures | -8.32B | -3.44B |
| Free Cash Flow | 5.77B | 683.20M |
| FCF Margin | 7.5% | 1.7% |
| Debt Repayment | -1.98B | -1.34B |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | FORTIS | ASTERDM |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 754.96M | 516.94M |
| Float Shares | 489.31M | 191.44M |
| % Held by Insiders | 35.19% | 53.34% |
| % Held by Institutions | 46.99% | 31.94% |
| % Held by Public | 17.82% | 14.72% |
Dividend Analysis & Yield Comparison: Fortis Healthcare Ltd. vs Aster DM Healthcare Ltd.
| Metric | FORTIS | ASTERDM |
|---|---|---|
| Last 12-Month Dividend | ₹1.00 | ₹6.00 |
| Last 12-Month Dividend Yield | 0.12% | 1.05% |
| 3-Year Avg Annual Dividend | ₹1.00 | ₹41.33 |
| 3-Year Avg Dividend Yield | 0.21% | 11.45% |
| 3-Year Total Dividends | ₹3.00 | ₹124.00 |
| Ex-Dividend Date | Jul 25, 2025 | Feb 10, 2025 |